| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |